Magnetic resonance spectroscopy in anxiety disorders

Acta Neuropsychiatrica

Volumn 20, Issue 2, 2008, Pages 56-71

  Trzesniak, Clarissa ^a   Araújo, David ^a   Crippa, José Alexandre S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; MRS; Neurochemistry; Neuroimaging; Psychiatry; Spectroscopy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINE; CLOMIPRAMINE; CLONAZEPAM; CREATINE; CREATINE PHOSPHATE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; GLUTAMIC ACID; GLUTAMINE; HALOPERIDOL; INOSITOL; LACTATE SODIUM; LACTIC ACID; MOOD STABILIZER; N ACETYLASPARTIC ACID; PAROXETINE; PHOSPHORYLCHOLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; BRAIN METABOLISM; CELL VIABILITY; HUMAN; NERVE CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; REVIEW; SOCIAL PHOBIA; SYSTEMATIC REVIEW;

EID: 41049117284     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2008.00270.x     Document Type: Review

References (77)

1. Malhi GS, Valenzuela M, Wen W, Sachdev P. Magnetic resonance spectroscopy and its applications in psychiatry. Aust N Z J Psychiatry 2002 36 : 31 43.
2. Ross AJ, Sachdev PS. Magnetic resonance spectroscopy in cognitive research. Brain Res Rev 2004 44 : 83 102.
3. Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurological disorders. Eur J Radiol 1999 30 : 125 131.
4. 1H MRS of brain. Magn Reson Imag 1996 14 : 281 292.
5. Wang PW, Napapon S, Chandler RA, Ketter TA. Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders. Acta Neuropsychiatr 2006 18 : 120 126.
6. Rosenthal R. Judgement studies. Design, analysis, and meta-analysis. Cambridge : Cambridge University Press, 1987.
7. Mathew SJ, Mao X, Coplan JD et al. Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study. Am J Psychiatry 2004 161 : 1119 1121.
8. Coplan JD, Mathew SJ, Mao X et al. Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma. Psychiatry Res 2006 147 : 27 39.
9. Davidson JR, Krishnan KR, Charles HC et al. Magnetic resonance spectroscopy in social phobia: preliminary findings. J Clin Psychiatry 1993 54 : 19 25.
10. 1H-MRS at 4 Tesla. Neuroreport 2005 16 : 183 186.
11. Tupler LA, Davidson JR, Smith RD, Lazeyras F, Charles HC, Krishnan KR. A repeat proton magnetic resonance spectroscopy study in social phobia. Biol Psychiatry 1997 42 : 419 424.
12. Miner CM, Davidson JR, Potts NL, Tupler LA, Charles HC, Krishnan KR. Brain fluoxetine measurements using fluorine magnetic resonance spectroscopy in patients with social phobia. Biol Psychiatry 1995 38 : 696 698.
13. Dager SR, Marro KI, Richards TL, Metzger GD. Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. Am J Psychiatry 1994 151 : 57 63.
14. 1H-MRS investigation of brain metabolic changes during lactate-induced panic. Psychiatry Res 1997 76 : 89 99.
15. Dager SR, Friedman SD, Heide A et al. Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Arch Gen Psychiatry 1999 56 : 70 77.
16. Friedman SD, Dager SR, Richards TL, Petropoulos H, Posse S. Modeling brain compartmental lactate response to metabolic challenge: a feasibility study. Psychiatry Res 2000 98 : 55 66.
17. Dager SR, Strauss WL, Marro KI, Richards TL, Metzger GD, Artru AA. Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry 1995 152 : 666 672.
18. Friedman SD, Mathis CM, Hayes C, Renshaw P, Dager SR. Brain pH response to hyperventilation in panic disorder: preliminary evidence for altered acid-base regulation. Am J Psychiatry 2006 163 : 710 715.
19. Layton ME, Friedman SD, Dager SR. Brain metabolic changes during lactate-induced panic: effects of gabapentin treatment. Depress Anxiety 2001 14 : 251 254.
20. 31P-MRS. Biol Psychiatry 1996 40 : 785 793.
21. Massana G, Gasto C, Junque C et al. Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with (1)H magnetic resonance spectroscopy. Neuroimage 2002 16 : 836 842.
22. 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 2001 58 : 556 561.
23. Goddard AW, Mason GF, Appel M et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 2004 161 : 2186 2193.
24. Ham BJ, Sung Y, Kim N et al. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study. Prog Neuropsychopharmacol Biol Psychiatry 2007 30 : 403 411.
25. Schuff N, Marmar CR, Weiss DS, Neylan TC, Schoenfeld F, Fein G, Weiner MW. Reduced hippocampal volume and n-acetyl aspartate in posttraumatic stress disorder. Ann N Y Acad Sci 1997 821 : 516 520.
26. Schuff N, Neylan TC, Lenoci MA et al. Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry 2001 50 : 952 959.
27. Villarreal G, Petropoulos H, Hamilton DA et al. Proton magnetic resonance spectroscopy of the hippocampus and occipital white matter in PTSD: preliminary results. Can J Psychiatry 2002 47 : 666 670.
28. Neylan TC, Schuff N, Lenoci M, Yehuda R, Weiner MW, Marmar CR. Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol Psychiatry 2003 54 : 1118 1121.
29. Mohanakrishnan Menon P, Nasrallah HA, Lyons JA, Scott MF, Liberto V. Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry Res 2003 123 : 101 108.
30. Mahmutyazicioglu K, Konuk N, Ozdemir H, Atasoy N, Atik L, Gundogdu S. Evaluation of the hippocampus and the anterior cingulate gyrus by proton MR spectroscopy in patients with post-traumatic stress disorder. Diagn Interven Radiol 2005 11 : 125 129.
31. Li L, Chen S, Liu J, Zhang J, He Z, Lin X. Magnetic resonance imaging and magnetic resonance spectroscopy study of deficits in hippocampal structure in fire victims with recent-onset posttraumatic stress disorder. Can J Psychiatry 2006 51 : 431 437.
32. Ham BJ, Chey J, Yoon SJ et al. Decreased N-acetyl-aspartate levels in anterior cingulate and hippocampus in subjects with post-traumatic stress disorder: a proton magnetic resonance spectroscopy study. Eur J Neurosci 2007 25 : 324 329.
33. Freeman T, Kimbrell T, Booe L et al. Evidence of resilience: neuroimaging in former prisoners of war. Psychiatry Res 2006 146 : 59 64.
34. Freeman TW, Cardwell D, Karson CN, Komoroski RA. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Reson Med 1998 40 : 66 71.
35. Brown S, Freeman T, Kimbrell T, Cardwell D, Komoroski R. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of former prisoners of war with and without posttraumatic stress disorder. J Neuropsychiatr and Clin Neurosci 2003 15 : 367 370.
36. Kimbrell T, Leulf C, Cardwell D, Komoroski RA, Freeman TW. Relationship of in vivo medial temporal lobe magnetic resonance spectroscopy to documented combat exposure in veterans with chronic posttraumatic stress disorder. Psychiatry Res 2005 140 : 91 94.
37. De Bellis MD, Keshavan MS, Spencer S, Hall J. N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. Am J Psychiatry 2000 157 : 1175 1177.
38. Seedat S, Videen JS, Kennedy CM, Stein MB. Single voxel proton magnetic resonance spectroscopy in women with and without intimate partner violence-related posttraumatic stress disorder. Psychiatry Res 2005 139 : 249 258.
39. 1H-MR spectroscopic findings. Korean J Radiol 2003 4 : 79 84.
40. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000 39 : 1096 1103.
41. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res 2006 146 : 137 147.
42. 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998 155 : 1584 1591.
43. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 1997 74 : 173 176.
44. Ohara K, Isoda H, Suzuki Y et al. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Res 1999 92 : 83 91.
45. Mirza Y, O'Neill J, Smith EA et al. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. J Child Neurol 2006 21 : 106 111.
46. Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J Child Neurol 2001 16 : 636 641.
47. Smith EA, Russell A, Lorch E et al. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry 2003 54 : 1399 1405.
48. Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol Psychiatry 2000 47 : 174 182.
49. Jang JH, Kwon JS, Jang DP et al. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. Am J Psychiatry 2006 163 : 1202 1207.
50. Sumitani S, Harada M, Kubo H, Ohmori T. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry Res 2007 154 : 85 92.
51. Rosenberg DR, Mirza Y, Russell A et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 2004 43 : 1146 1153.
52. Kitamura H, Shioiri T, Kimura T, Ohkubo M, Nakada T, Someya T. Parietal white matter abnormalities in obsessive-compulsive disorder: a magnetic resonance spectroscopy study at 3-Tesla. Acta Psychiatr Scand 2006 114 : 101 108.
53. Renshaw PF, Guimaraes AR, Fava M et al. Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration. Am J Psychiatry 1992 149 : 1592 1594.
54. 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder. Am J Psychiatry 1997 154 : 516 522.
55. Vythilingam M, Heim C, Newport J et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 2002 159 : 2072 2080.
56. Bueno CH, Zangrossi H Jr., Nogueira RL, Soares VP, Viana MB. Panicolytic-like effect induced by the stimulation of GABAA and GABAB receptors in the dorsal periaqueductal grey of rats. Eur J Pharmacol 2005 516 : 239 246.
57. Zwanzger P, Rupprecht R. Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder. J Psychiatry Neurosci 2005 30 : 167 175.
58. Graeff FG, Silveira MC, Nogueira RL, Audi EA, Oliveira RM. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav Brain Res 1993 58 : 123 131.
59. Villarreal G, Hamilton DA, Petropoulos H et al. Reduced hippocampal volume and total white matter volume in posttraumatic stress disorder. Biol Psychiatry 2002 52 : 119 125.
60. Lindauer RJ, Vlieger EJ, Jalink M et al. Smaller hippocampal volume in Dutch police officers with posttraumatic stress disorder. Biolo Psychiatry 2004 56 : 356 363.
61. Wignall EL, Dickson JM, Vaughan P et al. Smaller hippocampal volume in patients with recent-onset posttraumatic stress disorder. Biol Psychiatry 2004 56 : 832 836.
62. Vythilingam M, Luckenbaugh DA, Lam T et al. Smaller head of the hippocampus in Gulf War-related posttraumatic stress disorder. Psychiatry Res 2005 139 : 89 99.
63. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain 1995 118 : 279 306.
64. Bremner JD. Traumatic stress: effects on the brain. Dialogues Clin Neurosci 2006 8 : 445 461.
65. Eichenbaum H. Declarative memory: insights from cognitive neurobiology. Annu Rev Psychol 1997 48 : 547 572.
66. Bremner JD, Randall P, Scott TM et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995 152 : 973 981.
67. Gilbertson MW, Shenton ME, Ciszewski A et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 2002 5 : 1242 1247.
68. Shin LM, Wright CI, Cannistraro PA et al. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 2005 62 : 273 281.
69. Modell JG, Mountz JM, Curtis GC, Greden JF. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1989 1 : 27 36.
70. Castle DJ, Phillips KA. Obsessive-compulsive spectrum of disorders: a defensible construct? Aust N Z J Psychiatry 2006 40 : 114 120.
71. Woods SW, Charney DS, Silver JM, Krystal JH, Heninger GR. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder. Psychiatry Res 1991 36 : 115 127.
72. Bernik MA, Gorenstein C, Vieira Filho AH. Stressful reactions and panic attacks induced by flumazenil in chronic benzodiazepine users. J Psychopharmacol 1998 12 : 146 150.
73. Aina Y, Susman JL. Understanding comorbidity with depression and anxiety disorders. J Am Osteopath Assoc 2006 106 : S9 S14.
74. 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res 2006 147 : 1 25.
75. Yildiz-Yesiloglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry 2006 30 : 969 995.
76. Bertolino A, Frye M, Callicott JH et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003 53 : 906 913.
77. Miller GA, Keller J. Psychology and neuroscience: making peace. Curr Dir Psycho Sci 2000 9 : 212 215.